BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 18265633)

  • 1. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
    Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
    Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
    Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
    Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
    Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors.
    Ohike N; Sato M; Hisayuki T; Imataka H; Sato S; Wada Y; Saito K; Takahashi M; Tajiri T; Kunimura T; Morohoshi T
    Pathol Int; 2007 Sep; 57(9):589-93. PubMed ID: 17685930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.
    Okada T; Masuda N; Fukai Y; Shimura T; Nishida Y; Hosouchi Y; Kashiwabara K; Nakajima T; Kuwano H
    Anticancer Res; 2006; 26(4B):3105-10. PubMed ID: 16886641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100P is an early developmental marker of pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of claudin expression in pancreatic cystic tumors.
    Lee JH; Kim KS; Kim TJ; Hong SP; Song SY; Chung JB; Park SW
    Oncol Rep; 2011 Apr; 25(4):971-8. PubMed ID: 21206985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
    Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
    Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
    J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
    Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
    Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
    Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
    Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis.
    Tamiolakis D; Simopoulos C; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Koutsougeras G; Alexiadis G; Menegaki M; Papadopoulos N
    Clin Exp Med; 2005 Oct; 5(3):106-11. PubMed ID: 16284732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
    Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does neoplastic gastrin expression remodel the embryonal pattern of the protein? A study in human pancreas.
    Tamiolakis D; Venizelos I; Simopoulos C; Kotini A; Jivannakis T; Papadopoulos N
    Hepatogastroenterology; 2004; 51(55):249-52. PubMed ID: 15011877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.
    Eguchi H; Ishikawa O; Ohigashi H; Tomimaru Y; Sasaki Y; Yamada T; Tsukuma H; Nakaizumi A; Imaoka S
    Surgery; 2006 Jun; 139(6):749-54. PubMed ID: 16782429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.